LOXAPINE- loxapine succinate tablet Estats Units - anglès - NLM (National Library of Medicine)

loxapine- loxapine succinate tablet

marlex pharmaceuticals inc - loxapine succinate (unii: x59sg0mryu) (loxapine - unii:ler583670j) - loxapine 5 mg - loxapine capsules, usp are indicated for the treatment of schizophrenia. the efficacy of loxapine in schizophrenia was established in clinical studies which enrolled newly hospitalized and chronically hospitalized acutely ill schizophrenic patients as subjects. contraindications loxapine is contraindicated in comatose or severe drug-induced depressed states (alcohol, barbiturates, narcotics, etc.). loxapine is contraindicated in individuals with known hypersensitivity to dibenzoxazepines.

PMS-LOXAPINE TABLET Canadà - anglès - Health Canada

pms-loxapine tablet

pharmascience inc - loxapine (loxapine succinate) - tablet - 2.5mg - loxapine (loxapine succinate) 2.5mg - miscellaneous antipsychotics

PMS-LOXAPINE TABLET Canadà - anglès - Health Canada

pms-loxapine tablet

pharmascience inc - loxapine (loxapine succinate) - tablet - 5mg - loxapine (loxapine succinate) 5mg - miscellaneous antipsychotics

PMS-LOXAPINE TABLET Canadà - anglès - Health Canada

pms-loxapine tablet

pharmascience inc - loxapine (loxapine succinate) - tablet - 10mg - loxapine (loxapine succinate) 10mg - miscellaneous antipsychotics

PMS-LOXAPINE TABLET Canadà - anglès - Health Canada

pms-loxapine tablet

pharmascience inc - loxapine (loxapine succinate) - tablet - 25mg - loxapine (loxapine succinate) 25mg - miscellaneous antipsychotics

PMS-LOXAPINE TABLET Canadà - anglès - Health Canada

pms-loxapine tablet

pharmascience inc - loxapine (loxapine succinate) - tablet - 50mg - loxapine (loxapine succinate) 50mg - miscellaneous antipsychotics

LOXAPINE capsule Estats Units - anglès - NLM (National Library of Medicine)

loxapine capsule

lannett company, inc. - loxapine succinate (unii: x59sg0mryu) (loxapine - unii:ler583670j) - loxapine 5 mg - loxapine capsules, usp are indicated for the treatment of schizophrenia. the efficacy of loxapine in schizophrenia was established in clinical studies which enrolled newly hospitalized and chronically hospitalized acutely ill schizophrenic patients as subjects. loxapine is contraindicated in comatose or severe drug-induced depressed states (alcohol, barbiturates, narcotics, etc.). loxapine is contraindicated in individuals with known hypersensitivity to dibenzoxazepines.

LOXAPINE capsule Estats Units - anglès - NLM (National Library of Medicine)

loxapine capsule

mylan institutional inc. - loxapine succinate (unii: x59sg0mryu) (loxapine - unii:ler583670j) - loxapine 10 mg - loxapine capsules are indicated for the treatment of schizophrenia. the efficacy of loxapine capsules in schizophrenia was established in clinical studies which enrolled newly hospitalized and chronically hospitalized acutely ill schizophrenic patients as subjects. loxapine capsules are contraindicated in comatose or severe drug-induced depressed states (alcohol, barbiturates, narcotics, etc.). loxapine is contraindicated in individuals with known hypersensitivity to dibenzoxazepines.

LOXAPINE capsule Estats Units - anglès - NLM (National Library of Medicine)

loxapine capsule

actavis pharma, inc. - loxapine succinate (unii: x59sg0mryu) (loxapine - unii:ler583670j) - loxapine 5 mg - loxapine capsules are indicated for the treatment of schizophrenia. the efficacy of loxapine in schizophrenia was established in clinical studies which enrolled newly hospitalized and chronically hospitalized acutely ill schizophrenic patients as subjects. loxapine is contraindicated in comatose or severe drug-induced depressed states (alcohol, barbiturates, narcotics, etc.). loxapine is contraindicated in individuals with known hypersensitivity to dibenzoxazepines.

LOXAPINE capsule Estats Units - anglès - NLM (National Library of Medicine)

loxapine capsule

mylan pharmaceuticals inc. - loxapine succinate (unii: x59sg0mryu) (loxapine - unii:ler583670j) - loxapine 5 mg - loxapine capsules are indicated for the treatment of schizophrenia. the efficacy of loxapine capsules in schizophrenia was established in clinical studies which enrolled newly hospitalized and chronically hospitalized acutely ill schizophrenic patients as subjects. loxapine capsules are contraindicated in comatose or severe drug-induced depressed states (alcohol, barbiturates, narcotics, etc.). loxapine is contraindicated in individuals with known hypersensitivity to dibenzoxazepines.